Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · IEX Real-Time Price · USD

9.10

-0.15 (-1.62%)

At close: Apr 25, 2024, 4:00 PM

9.30

+0.20 (2.20%)

After-hours: Apr 25, 2024, 7:39 PM EDT

Elicio Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-35.2	-28.21	-54.57	-80.11	-40.66	-25.01
Depreciation & Amortization	1.17	1.06	0.8	0.63	0.5	0
Share-Based Compensation	1.18	0.58	12.04	4.72	3.34	2.98
Other Operating Activities	0.15	4.39	-10.91	51.88	12.24	9.02
Operating Cash Flow	-32.69	-22.18	-52.64	-22.89	-24.59	-8.02
Capital Expenditures	-0.03	-0.65	-0.38	-0.04	-0.24	0
Investing Cash Flow	-0.03	-0.65	-0.38	-0.04	-0.24	0
Share Issuance / Repurchase	6.98	0.08	108.48	-0.48	-0.29	28.59
Debt Issued / Paid	10	0	0.29	32.12	5.27	3.15
Other Financing Activities	21.64	21.12	-1.6	20.77	-0.09	0
Financing Cash Flow	38.61	21.2	107.17	52.41	4.89	31.74
Exchange Rate Effect	0	0	0	-0.44	0	0
Net Cash Flow	5.89	-1.63	54.15	29.04	-19.94	23.72
Free Cash Flow	-32.73	-22.83	-53.03	-22.93	-24.83	-8.02
Free Cash Flow Margin	-	-	-187.29%	-796.15%	-1669.87%	-199.06%
Free Cash Flow Per Share	-6.47	-72.26	-18.77	-15.53	-17.20	-8.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).